Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmsc 5.25% Regulatory News (AG99)

Share Price Information for Glaxosmsc 5.25% (AG99)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 104.475
Bid: 102.90
Ask: 106.05
Change: -0.10 (-0.10%)
Spread: 3.15 (3.061%)
Open: 104.575
High: 0.00
Low: 0.00
Prev. Close: 104.575
AG99 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Information Update

30 Apr 2012 15:57

RNS Number : 3918C
GlaxoSmithKline Capital PLC
30 April 2012
 



 

ANNUAL INFORMATION UPDATE FOR GLAXOSMITHKLINE CAPITAL PLC FOR THE PERIOD 28 APRIL 2011 TO 30 APRIL 2012

 

 

In accordance with the requirements of Prospectus Rule 5.2.1R please find below an Annual Information Update for GlaxoSmithKline Capital plc (the "Company"). The information referred to in this Update was up to date at the time the information was published, but some information may now be out of date.

 

To avoid an unnecessarily lengthy document, the following are summaries of the information and documents published, or made available to the public, by the Company throughout the period 28 April 2011 to 30 April 2012.

 

Announcements made via RNS, a Regulatory Information Service

The announcements listed below were published on the London Stock Exchange via RNS, a Regulatory Information Service and can be obtained from their website www.londonstockexchange.com.

Date

Headline

24/04/2012

Annual Financial Report

03/08/2011

Publication of Prospectus

03/08/2011

Publication of Registration Document

02/08/2011

Half Yearly Report

28/04/2011

Annual Information Update

 

Documents filed at Companies House

 

All documents listed below were filed with the Registrar of Companies in England and Wales on or around the dates indicated, and can be obtained from Companies House via their website www.companieshouse.gov.uk.

 

 

Date

Document Type

Description of Document Filed

27/04/2012

AA

Accounts to 31/12/2011

27/09/2011

AR01

Annual Return

04/05/2011

AA

Accounts to 31/12/2010

Documents sent to shareholders

The following documents were published and/or sent to shareholders:

Date

Document

27/04/2012

Annual Report and Accounts

 

A copy of this Annual Information Update and copies of the documents referred to in it can be obtained from the Company Secretary at the Company's registered office:

 

 

Victoria Whyte

Company Secretary

GlaxoSmithKline Capital plc

980 Great West Road

Brentford

Middlesex

TW8 9GS

 

Tel: 020 8047 5000

 

 

V A Whyte

Company Secretary

 

30 April 2012

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIULLFESSRIIVIF
12
Date   Source Headline
30th Apr 20249:36 amRNSAnnual Financial Report
20th Dec 20234:44 pmRNSPublication of EMTN Suppl.Prospcts
19th Sep 20233:01 pmRNSEMTN Programme issue - publication of Final Terms
8th Aug 20231:05 pmRNSPublication of Base Prospectus
31st Jul 20234:57 pmRNSHalf-year Report
28th Apr 20235:09 pmRNSAnnual Financial Report
13th Feb 20235:35 pmRNSEMTN Notes repurchase results
22nd Nov 20224:00 pmRNSPublication of Supplementary EMTN Prospectus
18th Nov 20224:00 pmRNSPublication of EMTN Supplementary Prospectus
15th Nov 20223:53 pmRNSFinal results of outstanding Notes Tender Offer
15th Nov 20227:00 amRNSInterim results of outstanding Notes Tender Offer
8th Nov 20229:26 amRNSLaunch of Tender Offer for outstanding Notes
3rd Nov 20221:00 pmRNSPublication of Suppl.Prospcts
9th Sep 20229:11 amRNSPublication of Base Prospectus
2nd Aug 202212:51 pmRNSHalf-year Report
29th Apr 20221:00 pmRNSAnnual Financial Report
14th Apr 20222:30 pmRNSNotice of Optional Redemption
8th Dec 20211:35 pmRNSPublication of a Prospectus
29th Jul 202110:23 amRNSHalf-year Report
11th May 202111:30 amRNSEMTN Prospectus
22nd Apr 202111:21 amRNSAnnual Financial Report
26th Nov 202012:38 pmRNSEMTN Supplementary Prospectus
28th Sep 20203:40 pmRNSNotice of Optional Redemption
4th Aug 20206:30 pmRNSPublication of a Prospectus
31st Jul 20202:02 pmRNSReplacement: Half-year Report
29th Jul 20205:01 pmRNSHalf-year Report
7th May 20205:43 pmRNSPublication of Final Terms
5th May 20208:06 amRNSStabilisation Notice
4th May 202010:41 amRNSStabilisation Notice
30th Apr 20206:09 pmRNSAnnual Financial Report
30th Apr 20205:51 pmRNSPublication of a Prospectus
13th Mar 20205:32 pmRNSEMTN Prospectus Supplement Update
16th Oct 20199:43 amRNSPost Stabilisation Notice - GlaxoSmithKline
19th Sep 20193:37 pmRNSEMTN Programme Issuance of Bonds
16th Sep 20198:31 amRNSPre Stabilisation Notice - GlaxoSmithKline Capital
2nd Aug 20195:34 pmRNSPublication of Base Prospectus
24th Jul 20195:30 pmRNSGlaxoSmithKline Capital plc Half Yearly Report
26th Apr 201911:04 amRNSFinal Results
2nd Aug 20185:07 pmRNSPublication of Base Prospectus
26th Jul 20182:19 pmRNSHalf-year Report
17th May 20184:10 pmRNSPublication of Final Terms
11th May 201812:33 pmRNSPublication of Supplementary Prospectus
12th Apr 20183:01 pmRNSAnnual Financial Report
8th Sep 20174:39 pmRNSPublication of Final Terms
5th Sep 201710:19 amRNSStabilisation Notice
28th Jul 20174:45 pmRNSHalf-year Report
27th Apr 20174:26 pmRNSAnnual Financial Report
4th Aug 20163:50 pmRNSPublication of a Prospectus
27th Jul 20163:52 pmRNSHalf-year Report
26th Apr 20164:09 pmRNSAnnual Financial Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.